Reporter July 10 2015
Drug signaling networks
Jul. 15, 2015—Vanderbilt investigators have developed a new algorithm to understand the networks of signaling molecules that control drug action.
Hhex on cancer
Jul. 13, 2015—A new mouse model demonstrates that the Hhex gene – which is linked to blood cancers – is critical for normal blood cell production.
Delivering cells for heart repair
Jul. 10, 2015—A polymer hydrogel material developed by Vanderbilt scientists improved the delivery of stem cells for heart repair.
Signals of schizophrenia
Jul. 9, 2015—Vanderbilt researchers have discovered a possible molecular mechanism of schizophrenia that could lead to new treatments for the disorder.
VUMC lands major pharmacogenomics grant
Jul. 9, 2015—Vanderbilt University Medical Center has received a five-year, $12.8 million grant from the federal government to develop better ways to predict how patients will respond to the drugs they’re given.
Gates grant bolsters study of Tdap boosters in pregnant women
Jul. 9, 2015—Kathryn Edwards, M.D., director of the Vanderbilt Vaccine Research Program, has received a $307,000 grant from the Bill & Melinda Gates Foundation to study the immune responses of pregnant women who receive the Tdap (reduced-dose acellular pertussis vaccines combined with tetanus and diphtheria toxoids) vaccine.
Harvey named senior VP of Revenue Cycle Services
Jul. 9, 2015—Gayla Harvey has been named senior vice president of Revenue Cycle Services and Payer Strategy for Vanderbilt University Medical Center.
Move to new ICD-10 medical coding system progressing
Jul. 9, 2015—A team of Vanderbilt University Medical Center project managers has been working in recent months to train staff and transition clinics to a new medical coding and reporting system set to go into effect later this year.
Arteaga, AACR push for cancer research funding
Jul. 9, 2015—Carlos L. Arteaga, M.D., director of the Center for Cancer Targeted Therapies and director of the Breast Cancer Program at Vanderbilt-Ingram Cancer Center (VICC), recently joined other cancer research leaders in a meeting with members of Congress to discuss precision medicine in cancer and the need for continued federal support for cancer research.
Guengerich named interim editor of noted journal JBC
Jul. 9, 2015—Vanderbilt University’s F. Peter (Fred) Guengerich, Ph.D., has been named interim editor-in-chief of the Journal of Biological Chemistry (JBC).
Update from Kevin Johnson about Clinical Systems 2.0
Jul. 9, 2015—CS 2.0 started with McKesson announcing that the Horizon suite of software used at VUMC would no longer be supported in 2018. We are using this announcement as a motivator to evaluate all our systems and plan for what our patients, our staff and our faculty need in the future.
Improving patients’ quality of life drives Lind’s clinical care
Jul. 9, 2015—As a gastroenterologist, Christopher Lind, M.D., says he is often the “butt” of jokes, but few people truly appreciate the role the gut plays in their happiness.
